lanthanum has been researched along with limestone in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.90) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (30.43) | 29.6817 |
| 2010's | 40 (57.97) | 24.3611 |
| 2020's | 6 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Elder, JA; Lehninger, AL | 1 |
| Herman, TS; Lott, JA | 1 |
| Balducci, A; Coen, G; Curic, S; D'Haese, PC; De Broe, ME; Dimkovic, N; Djukanovic, L; Ferreira, A; Freemont, TJ; Hutchison, A; Pejanovic, S; Popovic, M; Sikole, A; Spasovski, GB; Sulkova, S; Sulowicz, W; Swanepoel, C; Torres, A | 1 |
| Bleyer, AJ | 1 |
| Freemont, T; Malluche, HH | 1 |
| Asmus, G; Backs, W; Hutchison, AJ; Jamar, R; Maes, B; Mohamed, E; Schmieder, R; Vanwalleghem, J; Vosskuhler, A | 2 |
| Denton, J; Freemont, AJ; Hoyland, JA | 1 |
| Becaus, I; Billiouw, JM; De Meester, J; Lornoy, W; Van Malderen, PA; Van Pottelberge, M | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Orita, H; Sakaguchi, T; Shigematsu, T | 1 |
| Shigematsu, T | 1 |
| Koiwa, F; Sato, Y | 1 |
| Taniguchi, M | 1 |
| De Vos, JY; Elseviers, M | 1 |
| Alonso, M; Andrés, E; Ballarín, J; Bover, J; Canal, C; Farré, N; Olaya, MT; Quílez, B | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Shigematsu, T; Skaguchi, T | 1 |
| Fitchett, D; Jamal, SA; Lok, CE; Mendelssohn, DC; Tsuyuki, RT | 1 |
| Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
| Curran, MP; Robinson, DM | 1 |
| Rees, L; Shroff, RC | 1 |
| Noto, L | 1 |
| Damment, SJ | 1 |
| Kerr, PG; Lau, KK; Polkinghorne, KR; Toussaint, ND | 1 |
| Anstey, CM; Gray, NA; Hollett, PR; Krishnasamy, R; Vardesh, DL | 1 |
| Negi, S; Shigematsu, T | 1 |
| Hanba, Y; Masumoto, A; Moribata, M; Shigemathu, T | 1 |
| Chiyotanda, S; Fujimoto, S; Fukudome, K; Kitamura, K; Sato, Y; Toida, T; Yamada, K | 1 |
| Choi, HY; Lee, HY; Lee, YK; Shin, SK | 1 |
| Aljama, P; Almadén, Y; Martín-Malo, A; Ojeda, R; Rodríguez, M; Soriano, S | 1 |
| Furui, H; Gotoh, J; Hattori, M; Horie, T; Iida, J; Kawamura, A; Kukita, K; Meguro, J; Onodera, K; Tamaki, T; Tsuchihashi, S; Yonekawa, M | 1 |
| Hasegawa, Y; Kamo, Y; Kikuchi, N; Matsuda, E; Sekino, H; Sekino, M; Takeuchi, K | 1 |
| Hong, Z; Ishizu, T; Kaneko, Y; Matsunaga, T; Taru, Y | 1 |
| Ando, R; Chida, Y; Shinoda, T; Suzuki, T; Tagawa, H; Takagi, M; Tanaka, Y; Yamasaki, M | 1 |
| Adachi, T; Ando, R; Fukami, K; Hazama, T; Kaida, Y; Kohno, K; Kusumoto, T; Manabe, R; Nakayama, Y; Okuda, S; Sakai, K; Ueda, S; Wada, Y; Yamagishi, S | 1 |
| Furuya, R; Hidaka, S; Ishioka, K; Iwagami, M; Kobayashi, S; Maesato, K; Mochida, Y; Moriya, H; Ohtake, T; Oka, M; Tsutsumi, D | 1 |
| Wada, K; Wada, Y | 1 |
| Kong, XL; Li, WB; Wang, ZS; Wei, Y | 1 |
| Galani, VJ; Prajapati, VA; Shah, PR | 1 |
| Fukuda, M; Ikeda, Y; Kishi, T; Miyazono, M; Nonaka, Y; Sanai, T; Sato, S; Takashima, T; Yoshizaki, M | 1 |
| Hara, K; Kishi, Y; Kurosawa, N; Obara, Y; Takada, D; Yamashiro, H | 1 |
| Hida, M; Hyodo, T; Ishii, D; Iwamura, M; Kawakami, J; Kurata, Y; Mikami, N; Wakai, H; Yoshida, K | 1 |
| Iida, A; Matsuo, A; Matsushita, M; Miyamoto, K; Tanimoto, M | 1 |
| Sun, J; Wang, R; Yang, XW; Zhai, CJ | 1 |
| Kitazono, T; Noguchi, H; Ooboshi, H; Tatsumoto, N; Tokumoto, M; Tsuruya, K; Yamada, S | 1 |
| Imanishi, Y; Inaba, M; Ishimura, E; Nagayama, H; Okuno, S; Shoji, S; Yamada, S | 1 |
| Kobayashi, M; Maruyama, I; Maruyama, K; Tatemichi, S; Yaguchi, A; Yonekubo, S | 1 |
| Gutekunst, L | 1 |
| Akizawa, T; Fukagawa, M; Hirakata, H; Kagimura, T; Kaneda, H; Ogata, H | 1 |
| Matsuda, H; Miyazaki, M; Oka, Y | 1 |
| Anderson, CA; Nguyen, HA; Rifkin, DE | 1 |
| Chang, YM; Chen, IL; Hsu, KS; Huang, YT; Jhen, RN; Kao, JL; Liou, HH; Liu, MC; Shiao, CC; Tsai, SC; Tung, NY; Yang, CL | 1 |
| Fujii, H; Goto, S; Kono, A; Kono, K; Nakai, K; Nishi, S; Nishii, T | 1 |
| Wang, S; Zhang, C; Zhang, X; Zhao, S | 1 |
| Neradova, A; Schumacher, SP; Schurgers, LJ; Vervloet, MG | 1 |
| Garg, AX; Habbous, S; Martin, J; Przech, S; Sarma, S | 1 |
| Ando, T; Ito, K; Minegishi, A; Nagano, N; Ogawa, T; Tsutsui, T | 1 |
| Kinoshita, O; Motomura, N; Ono, M; Yamauchi, H | 1 |
| Gao, Y; Li, Y; Lv, C; Wang, G; Wang, Z | 1 |
| Fujii, H; Goto, K; Goto, S; Kono, K; Nishi, S; Watanabe, K | 1 |
| Fujikawa, K; Hiroyoshi, T; Isoyama, N; Kuro-O, M; Matsuyama, H; Miura, Y; Nagata, Y; Nakamura, K | 1 |
| Fujii, H; Goto, S; Kono, K; Nishi, S; Watanabe, K | 1 |
| Akizawa, T; Fukagawa, M; Fukushima, M; Hirakata, H; Kagimura, T; Ogata, H | 1 |
| Wang, L; Yang, J; Zhang, X | 1 |
| Liao, PD; Xu, JP; Zeng, RX; Zhang, MZ | 1 |
| Akizawa, T; Fukagawa, M; Hirakata, H; Kagimura, T; Ogata, H | 1 |
20 review(s) available for lanthanum and limestone
| Article | Year |
|---|---|
Phosphate binder usage in kidney failure patients.
Topics: Acetates; Aluminum Compounds; Calcium Carbonate; Calcium Compounds; Clinical Trials as Topic; Epoxy Compounds; Humans; Iron Compounds; Ketoglutaric Acids; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
[Phosphate binder up to date].
Topics: Aluminum Hydroxide; Calcium Carbonate; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Sevelamer | 2007 |
[Management of phosphate in chronic kidney disease--Chemistry and history of phosphate binder].
Topics: Administration, Oral; Aluminum Compounds; Calcium Carbonate; Chronic Disease; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Diseases; Lanthanum; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2009 |
[Use of phosphate binder in predialysis patients].
Topics: Calcium Carbonate; Chronic Disease; Dialysis; Drug Approval; Humans; Hyperphosphatemia; Japan; Kidney Diseases; Lanthanum; Polyamines; Prognosis; Sevelamer | 2009 |
Update on the treatment of chronic kidney disease-mineral and bone disorder.
Topics: Aluminum Compounds; Calcinosis; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet, Protein-Restricted; Dietetics; Humans; Kidney Failure, Chronic; Lanthanum; Naphthalenes; Nephrology; Nutrition Assessment; Nutritive Value; Parathyroidectomy; Patient Care Team; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer; Vitamin D | 2009 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
[Clinical aspect of recent progress in phosphate metabolism. Management of hyperphosphagtemia].
Topics: Acetates; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Chelating Agents; Drug Design; Gels; Humans; Hyperphosphatemia; Lanthanum; Macromolecular Substances; Phosphorus, Dietary; Polyamines; Polymers; Renal Dialysis; Sevelamer | 2009 |
The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cause of Death; Chelating Agents; Chronic Disease; Humans; Kidney Diseases; Lanthanum; Polyamines; Sevelamer | 2009 |
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
Lanthanum carbonate: a review of its use in lowering serum phosphate in patients with end-stage renal disease.
Topics: Administration, Oral; Adult; Animals; Calcium Carbonate; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Time Factors | 2009 |
Phosphate binders in CKD: chalking out the differences.
Topics: Calcium; Calcium Carbonate; Child; Diet; Humans; Hyperparathyroidism; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Vascular Diseases | 2010 |
[Kidney and bone update : the 5-year history and future of CKD-MBD. Progress of phosphate binders].
Topics: Aluminum Hydroxide; Calcium Carbonate; Chelating Agents; Cholestyramine Resin; Chronic Disease; Diet, Protein-Restricted; Drug Design; Humans; Hyperphosphatemia; Ion Exchange Resins; Kidney Diseases; Lanthanum; Phosphorus, Dietary; Polyamines; Sevelamer | 2012 |
Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.
Topics: Bone Density; Calcium; Calcium Carbonate; Chelating Agents; Humans; Hypercalcemia; Lanthanum; Parathyroid Hormone; Phosphorus; Radiography; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
Topics: Calcium Carbonate; Female; Humans; Lanthanum; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic | 2015 |
An Update on Phosphate Binders: A Dietitian's Perspective.
Topics: Aluminum Hydroxide; Calcium Carbonate; Diet; Dose-Response Relationship, Drug; Humans; Hyperphosphatemia; Lanthanum; Nutritionists; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic | 2016 |
Nutrition Interventions in Chronic Kidney Disease.
Topics: Body Weight; Calcium Carbonate; Cardiovascular Diseases; Chelating Agents; Diet; Diet, Mediterranean; Dyslipidemias; Exercise; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperglycemia; Lanthanum; Phosphorus, Dietary; Protein-Energy Malnutrition; Renal Insufficiency, Chronic; Sodium, Dietary; Water-Electrolyte Balance | 2016 |
Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease.
Topics: Adult; Aged; Calcium Carbonate; Chelating Agents; Cost-Benefit Analysis; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Sevelamer | 2018 |
Effects of lanthanum carbonate and calcium carbonate on cardiovascular calcification in hemodialysis patients: A systematic review and meta-analysis.
Topics: Calcium; Calcium Carbonate; Chelating Agents; Fibroblast Growth Factor-23; Humans; Lanthanum; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2022 |
Effect of lanthanum carbonate on the progression of coronary artery calcification in hemodialysis patients: A meta-analysis of randomized controlled trials.
Topics: Adult; Calcium; Calcium Carbonate; Chelating Agents; Coronary Vessels; Humans; Lanthanum; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis | 2022 |
26 trial(s) available for lanthanum and limestone
| Article | Year |
|---|---|
A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.
Topics: Adult; Aged; Biomarkers; Bone and Bones; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis | 2003 |
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Calcium Carbonate; Female; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Vitamin D | 2005 |
Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Humans; Hypercalcemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Treatment Outcome | 2006 |
The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Calcitriol; Calcium; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Lanthanum; Male; Phosphorus; Renal Dialysis; Treatment Outcome | 2005 |
Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
Topics: Aluminum Hydroxide; Bicarbonates; Calcium; Calcium Carbonate; Dialysis Solutions; Female; Humans; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus; Phosphorus, Dietary; Prospective Studies; Renal Dialysis; Serum Albumin | 2006 |
Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia.
Topics: Antacids; Calcium Carbonate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Treatment Outcome | 2008 |
Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.
Topics: Adult; Aged; Aortic Diseases; Aortography; Biomarkers; Bone Density; Calcinosis; Calcium; Calcium Carbonate; Chelating Agents; Disease Progression; Female; Humans; Kidney Diseases; Lanthanum; Linear Models; Lumbar Vertebrae; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Renal Dialysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Victoria | 2011 |
Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Analysis of Variance; Calcium; Calcium Carbonate; Chelating Agents; Chi-Square Distribution; Cross-Over Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypercalcemia; Hyperphosphatemia; Isoenzymes; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Tartrate-Resistant Acid Phosphatase; Vitamin D | 2012 |
Effect of lanthanum carbonate on phosphate control in continuous ambulatory peritoneal dialysis patients in Korea: a randomized prospective study.
Topics: Adult; Calcium; Calcium Carbonate; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Prospective Studies; Republic of Korea | 2013 |
The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Calcium Carbonate; Chelating Agents; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Renal Insufficiency, Chronic; Statistics, Nonparametric; Vitamin D | 2013 |
Study of prolonged administration of lanthanum carbonate in dialysis patients.
Topics: Aged; Calcium; Calcium Carbonate; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Time Factors; Treatment Outcome | 2013 |
Three-year follow-up of lanthanum carbonate therapy in hemodialysis patients.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2013 |
Efficacy of continuous oral administration of lanthanum carbonate over 24 months.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Calcium; Calcium Carbonate; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Medication Adherence; Middle Aged; Parathyroid Hormone; Phosphates; Polyamines; Practice Guidelines as Topic; Prospective Studies; Renal Dialysis; Sevelamer; Time Factors | 2013 |
Improvement of MBD parameters in dialysis patients by a switch to, and combined use of lanthanum carbonate: Josai Dialysis Forum collaborative study.
Topics: Bone Diseases; Calcium; Calcium Carbonate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2013 |
Effects of switching from calcium carbonate to lanthanum carbonate on bone mineral metabolism in hemodialysis patients.
Topics: Aged; Bone and Bones; Calcium; Calcium Carbonate; Female; Follow-Up Studies; Humans; Inflammation; Interleukin-6; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Real-Time Polymerase Chain Reaction; Renal Dialysis; RNA, Messenger; Vitamin D | 2013 |
Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study.
Topics: Aged; Calcinosis; Calcium; Calcium Carbonate; Chelating Agents; Coronary Artery Disease; Disease Progression; Female; Follow-Up Studies; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2013 |
Evaluation of aortic calcification with lanthanum carbonate vs. calcium-based phosphate binders in maintenance hemodialysis patients with type 2 diabetes mellitus: an open-label randomized controlled trial.
Topics: Aged; Aortic Diseases; Calcinosis; Calcium Carbonate; Chelating Agents; Diabetes Mellitus, Type 2; Disease Progression; Female; Humans; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Tomography, X-Ray Computed | 2014 |
Effect of calcium carbonate combined with calcitonin on hypercalcemia in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Calcium; Calcium Carbonate; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2014 |
Clinical effects of long-term (36-month) lanthanum carbonate administration in hemodialysis patients in Japan.
Topics: Aged; Calcium; Calcium Carbonate; Chelating Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Time Factors; Treatment Outcome | 2014 |
Design and baseline characteristics of the LANDMARK study.
Topics: Aged; Biomarkers; Calcium Carbonate; Cardiovascular Diseases; Chelating Agents; Clinical Protocols; Disease-Free Survival; Female; Humans; Hyperphosphatemia; Japan; Lanthanum; Male; Middle Aged; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Research Design; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients.
Topics: Aged; Biomarkers; Calcium Carbonate; Chelating Agents; Down-Regulation; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Hepcidins; Humans; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus, Dietary; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Taiwan; Time Factors; Treatment Outcome | 2017 |
Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease: A prospective pilot study.
Topics: Administration, Oral; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcium Carbonate; Coronary Artery Disease; Diabetes Complications; Female; Fibroblast Growth Factor-23; Humans; Lanthanum; Male; Middle Aged; Pilot Projects; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2017 |
Effects of oral activated charcoal on hyperphosphatemia and vascular calcification in Chinese patients with stage 3-4 chronic kidney disease.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Calcium Carbonate; Charcoal; Chelating Agents; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Phosphates; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Vascular Calcification | 2019 |
The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; alpha-2-HS-Glycoprotein; Calcium; Calcium Carbonate; Drug Substitution; Female; Fibroblast Growth Factor-23; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Prospective Studies; Renal Dialysis | 2020 |
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Topics: Aged; Calcium Carbonate; Cardiovascular Diseases; Female; Heart Disease Risk Factors; Hip Fractures; Humans; Hyperparathyroidism; Hyperphosphatemia; Incidence; Japan; Lanthanum; Male; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Survival Analysis; Vascular Calcification | 2021 |
Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial.
Topics: Calcium; Calcium Carbonate; Chelating Agents; Coronary Artery Disease; Humans; Hyperphosphatemia; Lanthanum; Phosphates; Renal Dialysis; Treatment Outcome; Vascular Calcification | 2022 |
23 other study(ies) available for lanthanum and limestone
| Article | Year |
|---|---|
Respiration-dependent transport of carbon dioxide into rat liver mitochondria.
Topics: Acetazolamide; Adenosine Diphosphate; Animals; Bicarbonates; Biological Transport, Active; Calcium; Calcium Carbonate; Calcium Isotopes; Carbon Dioxide; Carbonates; Carbonic Anhydrases; Hydrogen-Ion Concentration; Lanthanum; Magnesium; Male; Mitochondria, Liver; Osmolar Concentration; Oxygen Consumption; Rats; Ruthenium; Strontium; Uncoupling Agents | 1973 |
Increased autoanalyzer dialysis of calcium and magnesium in presence of protein.
Topics: Autoanalysis; Blood Proteins; Calcium; Calcium Carbonate; Chromatography, Ion Exchange; Dialysis; Evaluation Studies as Topic; Female; Humans; Hydrochloric Acid; Lanthanum; Magnesium; Male; Serum Albumin; Spectrum Analysis | 1971 |
Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate.
Topics: Adult; Bone Remodeling; Calcification, Physiologic; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Histological Techniques; Humans; Ilium; Lanthanum; Male; Osteocytes; Prospective Studies | 2005 |
Phosphate binders.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Sevelamer | 2006 |
Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
Topics: Calcium Carbonate; Chelating Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Europe; Humans; Kidney Failure, Chronic; Lanthanum; Phosphorus Metabolism Disorders; Randomized Controlled Trials as Topic; Renal Dialysis; United States | 2007 |
The use of phosphate binders: data from contributors to the European Practice Database.
Topics: Acetates; Aluminum Compounds; Analysis of Variance; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Databases, Factual; Dietetics; Drug Utilization; Europe; Health Care Surveys; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2009 |
Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Carbonate; Calcium Compounds; Chelating Agents; Humans; Kidney Failure, Chronic; Lanthanum; Middle Aged; New York; Nutritional Status; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Serum Albumin; Sevelamer; Treatment Outcome | 2011 |
Pharmacology of the phosphate binder, lanthanum carbonate.
Topics: Aluminum Hydroxide; Animals; Calcium; Calcium Carbonate; Chelating Agents; Dogs; Drug Evaluation, Preclinical; Feces; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Mice; Phosphates; Phosphorus Radioisotopes; Polyamines; Rats; Rats, Sprague-Dawley; Sevelamer | 2011 |
Impact of non-traditional phosphate binders and cinacalcet on haemodialysis patient biochemistry, pill burden and cost.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aluminum Hydroxide; Australia; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Costs; Female; Health Care Costs; Hemodialysis Units, Hospital; Humans; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2011 |
Combined therapy with lanthanum carbonate and calcium carbonate for hyperphosphatemia decreases serum FGF-23 level independently of calcium and PTH (COLC Study).
Topics: Adult; Aged; Antacids; Calcium; Calcium Carbonate; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis; Treatment Outcome; Young Adult | 2012 |
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome | 2014 |
A comparison of the long-term effects of lanthanum carbonate and calcium carbonate on the course of chronic renal failure in rats with adriamycin-induced nephropathy.
Topics: Animals; Blood Pressure; Calcium Carbonate; Disease Models, Animal; Doxorubicin; Glucuronidase; Kidney Failure, Chronic; Kidney Function Tests; Klotho Proteins; Lanthanum; Male; Rats; Time Factors | 2014 |
Increase in the dosage amount of vitamin D3 preparations by switching from calcium carbonate to lanthanum carbonate.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Calcium; Calcium Carbonate; Cholecalciferol; Dose-Response Relationship, Drug; Female; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prognosis; Renal Dialysis; Retrospective Studies | 2014 |
The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats.
Topics: Animals; Calcium Carbonate; Ferric Compounds; Intestinal Absorption; Lanthanum; Male; Phosphorus; Rats; Rats, Sprague-Dawley | 2014 |
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Topics: Adenine; Animal Feed; Animals; Calcinosis; Calcium Carbonate; Cellular Senescence; Disease Models, Animal; Disease Progression; Fibrosis; Immunohistochemistry; Inflammation; Kidney; Kidney Failure, Chronic; Lanthanum; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Phosphates; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Uremia; Vascular Calcification | 2015 |
Comparison of Phosphate Binding Capacities of PA21, A Novel Phosphate Binder, with those of other Phosphate Binders in vitro and in vivo.
Topics: Administration, Oral; Animals; Calcium Carbonate; Chelating Agents; Drug Combinations; Ferric Compounds; Hyperphosphatemia; Lanthanum; Male; Phosphates; Rats; Rats, Sprague-Dawley; Sevelamer; Sucrose | 2016 |
Did Lanthanum Carbonate Improve Prognosis in Patients Requiring Chronic Hemodialysis in the Kawashima Study?
Topics: Calcium Carbonate; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Prognosis; Renal Dialysis | 2016 |
Effects of Lanthanum Carbonate on Coronary Artery Calcification and Cardiac Abnormalities After Initiating Hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Calcium Carbonate; Chelating Agents; Coronary Vessels; Female; Fibroblast Growth Factor-23; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Calcification | 2018 |
Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Drug Combinations; Ferric Compounds; Hydrogen-Ion Concentration; Kinetics; Lanthanum; Magnesium; Phosphates; Sevelamer; Sucrose | 2019 |
Phosphate Binders Derived from Natural Ores Contain Many Kinds of Metallic Elements Besides Their Active Ingredient Metals.
Topics: Calcium Carbonate; Chelating Agents; Drug Combinations; Ferric Compounds; Japan; Lanthanum; Metals; Phosphates; Polyamines; Sevelamer; Spectrophotometry, Atomic; Sucrose | 2018 |
Lanthanum carbonate, a phosphate binder, inhibits calcification of implanted aortic allografts in a rat model.
Topics: Allografts; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Blood Vessel Prosthesis; Calcium; Calcium Carbonate; Lanthanum; Male; Models, Animal; Phosphorus; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Vascular Calcification | 2019 |
Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients.
Topics: Aged; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Calcium Carbonate; Female; Humans; Lanthanum; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Tartrate-Resistant Acid Phosphatase | 2019 |
Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Calcinosis; Calcium Carbonate; Chelating Agents; Disease Progression; Female; Heart Valve Diseases; Humans; Kidney Diseases; Lanthanum; Male; Middle Aged; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Time Factors; Treatment Outcome | 2020 |